Immunologic determinants of susceptibility to experimental glomerulonephritis: Role of cellular immunity

Kidney International

Volumn 51, Issue 3, 1997, Pages 646-652

  Coelho, Sandra N ^a   Saleem, Sohail ^c   Konieczny, Bogumila T ^c   Parekh, Kannan R ^c   Baddoura, Fady K ^c   Lakkis, Fadi G ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; GLOMERULONEPHRITIS; IMMUNE COMPLEX NEPHRITIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030968635     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.94     Document Type: Article

References (33)

1. WILSON CB: Renal response to immunologic glomerular injury, in The Kidney (5th ed, vol. 2), edited by BRENNER BM, Philadelphia, Saunders, 1996, p 1253
2. HOOKE DH, GEE DC, ATKINS RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31:961-972, 1987
3. NOLASCO FEB, CAMERON JS, HARTLEY B, COELHO A, HILDRETH G, REUBEN R: Intraglomerular T cells and monocytes in nephritis: Study with monoclonal antibodies. Kidney Int 31:1160-1166, 1987
4. TAM FWK, PUSEY CD: The role of T lymphocytes in extracapillary glomerulonephritis. J Nephrol 8:305-316, 1995
5. UNANUE ER, DIXON FJ: Experimental glomerulonephritis. IV. The autologous phase of nephrotoxic serum nephritis. J Exp Med 121:715-725, 1965
6. LOWRY RP, CLARKE FORBES RD, BLACKBURN JH: Immune reactivity and immunosuppressive intervention (TLI) in experimental nephritis. I. Immunopathologic correlates of accelerated autologous form of nephrotoxic serum nephritis. J Immunol 132:1001-1006, 1984
7. SCHREINER GF, COTRAN RS, PARDO V, UNANUE ER: A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med 47:369-384, 1978
8. HUANG XR, HOLDSWORTH SR, TIPPING PG: Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int 46:69-78, 1994
9. LI PK, POON AS, LAI KN: Molecular genetics of MHC class II alleles in Chinese patients with IgA nephropathy. Kidney Int 46:185-190, 1994
10. VAUGHAN RW, TIGHE MR, BOKI K, ALEXOUPOLOS S, PAPADAKIS J, LANCHBURY JS, WELSH KI, WILLIAMS DG: An analysis of HLA class II gene polymorphism in British and Greek idiopathic membranous nephropathy. Eur J Immunogen 22:179-186, 1995
11. BURNS AP, FISHER M, LI P, PUSEY CD, REES AJ: Molecular analysis of HLA class II genes in Goodpasture's disease. Quart J Med 88:93-100, 1995
12. STENGLEIN B, THOENES GH, GUNTHER E: Genetically controlled autologous immune complex glomerulonephritis in rats. J Immunol 115:895-897, 1975
13. ZANETTI M, BELLON B, VERROUST P, DRUET P: A search for circulating immune complex-like material during the course of auto-immune complex glomerulonephritis in Lewis and Brown Norway rats. Clin Exp Immunol 42:86-94, 1980
14. BOLTON WK, MAY WJ, STURGILL BC: Proliferative autoimmune glomerulonephritis in rats: A model for autoimmune glomerulonephritis in humans. Kidney Int 44:294-306, 1993
15. MOSMAN TR, SAD S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146, 1996
16. LAKKIS FG, BADDOURA FK, CRUET EN, PAREKH KR, FUKUNAGA M, MUNGER KA: Anti-inflammatory lymphokine mRNA expression in antibody-induced glomerulonephritis. Kidney Int 49:117-126, 1996
17. HANCOCK WW, KHOURY SJ, CARPENTER CB, SAYEGH MH: Differential effects of oral versus intrathymic administration of polymorphic major histocompatibility complex class II peptides on mononuclear and endothelial cell activation and cytokine expression during a delayed-type hypersensitivity response. Am J Pathol 144:1149-1158, 1994
18. HOLT PG, LEIVERS S, WARNER LA: Optimal culture conditions for in vitro antigen-induced proliferation of rat lymph node cells. J Immunol Meth 44:205-209, 1981
19. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
20. STUMBLES P, MASON D: Activation of CD4+ T cells in the presence of a nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro. J Exp Med 182:5-13, 1995
21. MURPHY E, HIENY S, SHER A, O'GARRA A: Detection of in vivo expression of interleukin-10 using a semiquantitative polymerase chain reaction method in Schistoma mansoni infected mice. J Immunol Meth 162:211-223, 1993
22. PAUL WE, SEDER RA: Lymphocyte responses and cytokines. Cell 76:241-251, 1994
23. BHAN AK, SCHNEEBERGER EE, COLLINS AB, MCCLUSKEY RT: Evidence for a pathogenic role of a cell-mediated immune mechanism in experimental glomerulonephritis. J Exp Med 148:246-260, 1978
24. BHAN AK, COLLINS AB, SCHNEEBERGER EE, MCCLUSKEY RT: A cell-mediated reaction against glomerular-bound immune complexes. J Exp Med 150:1410-1420, 1979
25. MOSSMAN TR, COFFMAN RL: TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173, 1989
26. SAYEGH MH, AKALIN E, HANCOCK WW, RUSSEL ME, CARPENTER CB, LINSLEY PS, TURKA LA: CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 181:1869-1874, 1995
27. SALGAME P, ABRAMS JS, CLAYBERGER C, GOLDSTEIN H, CONVITT J, MODLIN RL, BLOOM BR: Differing lymphokine profiles and functional subsets of human CD4+ and CD8+ T cell clones. Science 254:279-281, 1991
28. ROMAGNANI S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227-257, 1994
29. CHUNG IY, NORRIS JG, BENVENISTE EN: Differential tumor necrosis factor expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains. J Exp Med 173:801-811, 1991
30. SAOUDI A, KUHN J, HUYGEN K, DE KOZAK Y, VELU T, GOLDMAN M, DRUET P, BELLON B: TH2 activated cells prevent experimental autoimmune uveoretinitis, u TH1-dependent autoimmune disease. Eur J Immunol 23:3096-3103, 1993
31. DRUET E, SAPIN C, GUNTHER E, FEINGOLD N, DRUET P: Mercuric chloride induced anti-glomerular basement membrane antibodies in the rat. Genetic control. Eur J Immunol 7:348-351, 1977
32. OCHEL M, VOHR HW, PFEIFFER C, GLEICHMANN E: IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol 146:3006-3011, 1991
33. PRIGENT P, SAOUDI A, PANNETIER C, GRABER P, BONNEFOY J-Y, DRUET P, HIRSCH F: Mercuric chloride, a chemical responsible for T helper cell (Th)2-mediated autoimmunity in Brown Norway rats, directly triggers T cells to produce interleukin-4. J Clin Invest 96:1484-1489, 1995